Danaher (DHR)
(Delayed Data from NYSE)
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Yes, You Can Time the Market. Find out How - August 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Griffon (GFF) to Offer 8M Common Shares, To Pay Down Debts
by Zacks Equity Research
Griffon (GFF) intends to offer 8 million common shares to the public in an underwritten offer. The funds raised will be used for debt reduction and other corporate purposes.
Carlisle's (CSL) Board Okays 5% Hike in Quarterly Dividend
by Zacks Equity Research
Carlisle (CSL) rewards shareholders with a 5% hike in the quarterly dividend rate. This underpins its strong cash position.
The Zacks Analyst Blog Highlights: Danaher, Shopify and Lam Research
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher, Shopify and Lam Research
Earnings "Beats" Don't Matter Much: Global Week Ahead
by John Blank
Since overall S&P 500 earnings marks for Q2 are now down -35.7% y/y, and not -40%, this amounts to coming off a bottom, and just revealing deep analyst pessimism. A "beat" is not moving the dial much on stocks.
3 Zacks Rank #1s Making New Highs
by James Giaquinto
3 Zacks Rank #1s Making New Highs
Earnings Estimates Rising for Danaher (DHR): Will It Gain?
by Zacks Equity Research
Danaher (DHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
MRC Global (MRC) Q2 Earnings Surpass Estimates, Fall Y/Y
by Zacks Equity Research
MRC Global's (MRC) second-quarter 2020 earnings and revenues suffer from persistent lower demand on account of restricted customer spending.
Barnes (B) Q2 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Barnes (B) second-quarter 2020 revenues decline 37% year over year on lackluster performance across its segments.
General Electric (GE) Posts Loss in Q2, Expects Improvement
by Zacks Equity Research
General Electric's (GE) second-quarter 2020 results reflect the adverse impacts of the coronavirus outbreak. Earnings and cash are anticipated to improve sequentially in the second half of 2020.
Here's Why Danaher (DHR) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Crane (CR) Q2 Earnings and Revenues Beat Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) second-quarter 2020 revenues decline 19.5% year over year on lackluster performance across its segments.
Roper (ROP) Q2 Earnings & Revenues Top Estimates, Decline Y/Y
by Zacks Equity Research
Roper's (ROP) second-quarter 2020 revenues decline 2% year over year on weak performance across its Measurement & Analytical Solutions, and Process Technologies segments.
Danaher (DHR) Beats on Q2 Earnings, Gives Impressive View
by Zacks Equity Research
Danaher's (DHR) Q2 results gain from contribution from Cytiva and suffer from forex woes. Core sales in Q3 are expected to grow primarily on gains from Cytiva.
The Market Timing Secrets No One Talks About - July 23, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy
Danaher (DHR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 35.85% and 6.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Trendy Earnings Charts to Watch
by Tracey Ryniec
It's not all about tech companies. These 5 are in hot industries and have intriguing earnings charts.
The Zacks Analyst Blog Highlights: Bank of America, Abbott Laboratories, Chevron, Danaher and GlaxoSmithKline
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bank of America, Abbott Laboratories, Chevron, Danaher and GlaxoSmithKline
Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) Q2 revenues decline 22.1% year over year, owing to lackluster performance across all of its segments on a decline in sales volume due to the coronavirus outbreak-led issues.
Honeywell (HON) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Honeywell (HON) is expected to have gained from its efforts to maximize productivity and a surge in demand for healthcare products. The pandemic-led issues will likely get reflected in its Q2 results.
4 Must-Buy Stocks Poised to Beat on Q2 Earnings This Week
by Nalak Das
Despite this gloomy scenario, there are a handful of stocks with a favorable Zacks Rank set to beat on earnings estimates this week.
Danaher (DHR) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Will Danaher (DHR) Keep Its Earnings Streak Alive in Q2?
by Zacks Equity Research
Danaher's (DHR) Q2 results are anticipated to reflect healthy demand for some of its products and synergistic gains from Cytiva. Yet, subdued demand for a few other products is expected to have ailed.
Top Stock Reports for Bank of America, Abbott & Chevron
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Bank of America (BAC), Abbott Laboratories (ABT) and Chevron (CVX).